Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets

Biochem Biophys Res Commun. 1994 Jul 29;202(2):1069-75. doi: 10.1006/bbrc.1994.2037.

Abstract

Recently, it has been reported that an alpha-adrenergic antagonist phentolamine inhibits epinephrine-induced platelet aggregation but a beta-adrenergic antagonist propranolol did not. In this study, we examined the effects of alpha- and beta-adrenergic antagonist on cytosolic free calcium movements induced by epinephrine. An alpha-adrenergic antagonist phentolamine was found to inhibit the elevation of cytosolic free calcium concentration induced by epinephrine, while a beta-adrenergic antagonist propranolol had no effect on cytosolic free calcium concentration induced by epinephrine.

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology*
  • Adrenergic beta-Antagonists / pharmacology*
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Calcium / blood*
  • Cytosol / metabolism
  • Epinephrine / pharmacology*
  • Fibrinogen / pharmacology
  • Humans
  • Hydrogen-Ion Concentration
  • Phentolamine / pharmacology
  • Platelet Aggregation / drug effects*
  • Propranolol / pharmacology
  • Sodium / pharmacology

Substances

  • Adrenergic alpha-Antagonists
  • Adrenergic beta-Antagonists
  • Fibrinogen
  • Sodium
  • Propranolol
  • Calcium
  • Epinephrine
  • Phentolamine